Yahoo
NasdaqGM - Nasdaq Real Time Price USD

ANI Pharmaceuticals, Inc. (ANIP)

73.16 +1.45 (+2.02%)
At close: 4:00:01 PM EDT
73.16 0.00 (0.00%)
After hours: 4:00:12 PM EDT
Trade ANIP on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Nikhil Lalwani
President, CEO & Director 2.43M -- 1978
Mr. Stephen P. Carey
Senior VP of Finance & CFO 1.12M 1.98M 1971
Ms. Meredith W. Cook J.D.
Senior VP, General Counsel & Corporate Secretary 860.81k -- 1974
Mr. Christopher K. Mutz
Senior VP & Head of Rare Disease 1.27M -- 1972
Mr. Ori Gutwerg
Senior Vice President of Generics 964.15k 8.56k 1975
Mr. Muthusamy Shanmugam MS R.Ph.
Head of R&D and COO of New Jersey Operations -- -- 1968
Ms. Irina Rivkind Koffler
Vice President of Investor Relations -- -- --
Ms. Elizabeth Powell J.D.
Chief Compliance Officer & Head of Legal of Rare Disease -- -- --
Mr. Chad Gassert
Senior Vice President of Corporate Development & Strategy 849.71k -- 1976
Ms. Krista L. Davis
Senior VP & Chief Human Resources Officer -- -- 1973

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500 https://www.anipharmaceuticals.com
Sector: 
Healthcare
Full Time Employees: 
970

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Corporate Governance

ANI Pharmaceuticals, Inc.’s ISS Governance QualityScore as of October 1, 2026 is 1. The pillar scores are Audit: 6; Board: 1; Shareholder Rights: 1; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 5, 2026 at 12:30 PM UTC

ANI Pharmaceuticals, Inc. Earnings Date

Recent Events

August 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 7, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 17, 2026 at 12:00 AM UTC

S-8: Offering Registrations

May 21, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 8, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 9, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

April 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 3, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 27, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: